First Overseas Shipment of CanSinoBIO’s Convidecia Air™ Delivered to Morocco
CanSino Biologics Inc. (“CanSinoBIO” or “the Company”) (SSE: 688185, HKEX: 06185) today announced that the first batch of its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation (trade name: Convidecia Air™) has arrived in Morocco, providing... - December 30, 2022
Press Releases 1 - 1 of 1